CEAP Classification System for Chronic Venous Disease
The CEAP classification is a standardized system that categorizes chronic venous disease according to four key components: Clinical severity (C0-C6), Etiology (congenital, primary, secondary), Anatomic distribution (superficial, deep, perforator veins), and Pathophysiology (reflux, obstruction). 1
The Four Components of CEAP
Clinical Classification (C0-C6)
The clinical component grades disease severity from 0 to 6 based on objective clinical signs:
- C0: No visible or palpable signs of venous disease
- C1: Telangiectasias or reticular veins
- C2: Varicose veins (≥3 mm diameter in standing position)
- C3: Edema
- C4: Skin changes (pigmentation, eczema, lipodermatosclerosis)
- C5: Healed venous ulcer
- C6: Active venous ulcer
Each clinical class can be further designated as asymptomatic (A) or symptomatic (S). 1
Etiologic Classification
Documents the origin of venous disease:
- Congenital: Present since birth
- Primary: Undetermined cause (most common at 79% in clinical series)
- Secondary: Known cause such as post-thrombotic disease (18% in clinical series) 2
Anatomic Distribution
Identifies which venous systems are involved:
- Superficial veins: Great saphenous, small saphenous, tributaries
- Deep veins: Femoral, popliteal, tibial systems
- Perforator veins: Connecting superficial to deep systems 1
Pathophysiologic Mechanism
Defines the underlying dysfunction:
- Reflux: Retrograde flow from valvular incompetence (86% of cases, 80% of ulcer cases)
- Obstruction: Venous blockage
- Both: Combined reflux and obstruction 2
Clinical Application and Documentation
Use CEAP to provide structured documentation of venous disease severity and guide treatment decisions, but recognize its limitations for monitoring disease progression over time. 3
Practical Usage
- Document all four components for comprehensive assessment
- The clinical (C) classification is most commonly used in practice, though complete CEAP provides more detailed characterization 4
- In clinical series, C2-C3 disease has approximately 25% prevalence, while C4-C6 affects about 5% of the population 1
Key Limitations to Recognize
- CEAP is descriptive, not a severity scoring system - it categorizes disease but doesn't quantify symptom burden 3, 5
- Limited ability to monitor change over time or assess treatment response 3
- Does not incorporate symptom severity assessment 3
- No agreed-upon cutoff defines specific diagnoses like post-thrombotic syndrome 3
- C2 encompasses all types of varicose veins without differentiation 4
- C3 edema may be difficult to attribute solely to venous causes 4
Complementary Assessment Tools
For longitudinal assessment and treatment outcomes, use the Venous Clinical Severity Score (VCSS) rather than CEAP alone. The VCSS incorporates nine clinical parameters including pain, varicose veins, edema, pigmentation, inflammation, induration, ulcer characteristics, and compression use, providing quantitative assessment of disease severity and treatment response. 3, 6
Clinical Context
Understanding the relationship between CEAP components reveals important patterns: ulcers occur in 7% of primary venous disease but 44% of secondary (post-thrombotic) disease, highlighting the more severe nature of post-thrombotic pathology. 2 This information guides prognosis and treatment intensity decisions.